Pnc Financial Services Group, Inc. Cassava Sciences Inc Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 116 shares of SAVA stock, worth $197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116
Previous 2,338
95.04%
Holding current value
$197
Previous $68,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SAVA
# of Institutions
190Shares Held
16.4MCall Options Held
3.49MPut Options Held
8.08M-
Black Rock Inc. New York, NY3.22MShares$5.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$4.27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$1.71 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$1.69 Million0.0% of portfolio
-
Ubs Group Ag931KShares$1.58 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $68.2M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...